Experimental treatment pushed by ALS patients gets day before FDA, but agency unconvinced it works – Metro US
WASHINGTON (AP) — The Food and Drug Administration meets this week to consider approval of an experimental treatment for Lou Gehrig’s disease, the culmination of a yearslong lobbying effort by patients with the fatal neurodegenerative disease. Those advocates still face one giant hurdle: FDA regulators say the treatment hasn’t been shown to work. In documents […]
Source: metro.us
